The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab (NIVO) plus ipilimumab (IPI) or NIVO plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): First results of the CheckMate 648 study.
 
Ian Chau
No Relationships to Disclose
 
Yuichiro Doki
No Relationships to Disclose
 
Jaffer A. Ajani
No Relationships to Disclose
 
Jianming Xu
No Relationships to Disclose
 
Lucjan Wyrwicz
No Relationships to Disclose
 
Satoru Motoyama
No Relationships to Disclose
 
Takashi Ogata
No Relationships to Disclose
 
Hisato Kawakami
No Relationships to Disclose
 
Chih-Hung Hsu
No Relationships to Disclose
 
Antoine Adenis
No Relationships to Disclose
 
Farid El Hajbi
No Relationships to Disclose
 
Maria Di Bartolomeo
No Relationships to Disclose
 
Maria Ignez Freitas Melro Braghiroli
No Relationships to Disclose
 
Eva Holtved
No Relationships to Disclose
 
Ioannis Xynos
No Relationships to Disclose
 
Xuan Liu
No Relationships to Disclose
 
Ming Lei
No Relationships to Disclose
 
Kaoru Kondo
No Relationships to Disclose
 
Ken Kato
No Relationships to Disclose
 
Yuko Kitagawa
No Relationships to Disclose